GBM-associated mutations and altered protein expression are more common in young patients
Sherise D. Ferguson(The University of Texas MD Anderson Cancer Center), Amy B. Heimberger(Northwestern University), Geoffrey Barger(University of Maryland, Baltimore), Shouhao Zhou(Pennsylvania State University), Santosh Kesari(Cancer Institute (WIA)), Sandeep K. Reddy(Indian Institute of Technology Kharagpur), Joanne Xiu(Caris Life Sciences (United States)), Raymond J. Hohl(Pennsylvania State University), Roeland Verhaak(Broad Institute), Shiao-Pei Weathers(The University of Texas MD Anderson Cancer Center), Stephanie E. Weiss(Fox Chase Cancer Center)
Cited by 32
Related Papers
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
|The Lancet Oncology|2017|1.1k
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma
|New England Journal of Medicine|2016|1k
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
|Neuro-Oncology|2010|708
A pan-cancer proteomic perspective on The Cancer Genome Atlas
|Nature Communications|2014|641